Holen Sie sich die Stockscreener-App
3.76
2.17%
0.08
Handel nachbörslich:
3.76
Schlusskurs vom Vortag:
$3.68
Offen:
$3.7
24-Stunden-Volumen:
1.19M
Relative Volume:
0.81
Marktkapitalisierung:
$545.29M
Einnahmen:
$288.95M
Nettoeinkommen (Verlust:
$-119.03M
KGV:
-4.1755
EPS:
-0.9005
Netto-Cashflow:
$60.67M
1W Leistung:
+3.87%
1M Leistung:
+10.26%
6M Leistung:
+69.37%
1J Leistung:
-28.92%
1-Tages-Spanne:
$3.62
$3.78
1-Wochen-Bereich:
$3.37
$3.80
52-Wochen-Spanne:
$1.665
$6.21
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Firmenname
Maravai Lifesciences Holdings Inc
Sektor
Branche
Telefon
(858) 546-0004
Adresse
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Vergleichen Sie MRVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.76 | 533.68M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Neutral |
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-08-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Herabstufung | Goldman | Buy → Neutral |
| 2023-01-05 | Herabstufung | UBS | Buy → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-11-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Stifel | Buy |
| 2020-12-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-14 | Eingeleitet | UBS | Buy |
Alle ansehen
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Is Maravai LifeSciences Holdings Inc. (MAR) stock undervalued at current priceMarket Weekly Review & AI Driven Price Predictions - newser.com
Published on: 2025-11-21 05:22:01 - newser.com
Will Maravai LifeSciences Holdings Inc. stock outperform value stocksQuarterly Market Review & Accurate Buy Signal Notifications - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Maravai LifeSciences Holdings Inc. stock a top pick in earnings seasonJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - newser.com
Is Maravai LifeSciences Holdings Inc. (MAR) stock a good hedge against inflationEarnings Recap Report & Daily Growth Stock Tips - newser.com
Why Maravai LifeSciences Holdings Inc. (MAR) stock is a must watch tickerPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
How forex fluctuations impact Maravai LifeSciences Holdings Inc. (MAR) stockJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Is Maravai LifeSciences Holdings Inc. (MAR) stock suitable for passive index fundsSell Signal & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-19 14:21:53 - newser.com
Why Maravai LifeSciences Holdings Inc. stock appeals to dividend seekersTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Will Maravai LifeSciences Holdings Inc. (MAR) stock benefit from infrastructure bill2025 Trade Ideas & Weekly Momentum Picks - newser.com
Adversity is less terrifying than hope: Maravai LifeSciences Holdings Inc (MRVI) - Setenews
Maravai Lifesciences at Jefferies: Strategic Restructuring Focus By Investing.com - Investing.com Canada
Is Maravai LifeSciences Holdings Inc. stock a bargain at current levelsWeekly Trade Report & Precise Swing Trade Entry Alerts - newser.com
Will Maravai LifeSciences Holdings Inc. stock outperform tech sector in 2025Market Risk Report & Reliable Price Breakout Signals - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI.MX) Company Profile & Facts - Yahoo! Finance Canada
Why Maravai LifeSciences Holdings Inc. stock remains on watchlistsJuly 2025 Setups & Detailed Earnings Play Strategies - newser.com
[Form 4] MARAVAI LIFESCIENCES HOLDINGS, INC. Insider Trading Activity - Stock Titan
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai Lifesciences CEO Increases Stake with Significant Share Purchase (MRVI) - GuruFocus
Maravai Lifesciences Holdings Insider Bought Shares Worth $702,689, According to a Recent SEC Filing - MarketScreener
How Analyst Views on Maravai LifeSciences Are Shifting as the Story Evolves - Yahoo Finance
Goldman Sachs Downgrades Maravai LifeSciences Holdings (MRVI) - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Will Maravai LifeSciences Holdings Inc. stock reach all time highs in 2025Share Buyback & Real-Time Volume Spike Alerts - newser.com
Why Maravai LifeSciences Holdings Inc. stock remains resilientJuly 2025 Market Mood & Risk Managed Investment Strategies - newser.com
Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Maravai Lifesciences Holdings Inc-Aktie (MRVI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Brust Bernd | Chief Executive Officer |
Nov 11 '25 |
Buy |
3.24 |
157,201 |
509,331 |
157,201 |
| Brust Bernd | Chief Executive Officer |
Nov 12 '25 |
Buy |
3.21 |
93,358 |
299,679 |
250,559 |
| ORESHACK KURT | General Counsel |
Jan 31 '25 |
Sale |
5.03 |
25,000 |
125,750 |
167,618 |
0.53%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):